Novo Nordisk Warns of First Sales Drop Since Start of Ozempic
The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors. [Source]
Publication Date:Origin: nytimes.com
Category: Drugs (Pharmaceuticals)
Topics: investors, outlook, rosier, which, Lilly, especially, industry, weight-loss, rivals, struggled, drugmaker, Danish, high-flying, Ozempic, Start, Since, Sales, First, Warns, Nordisk
Source: https://www.nytimes.com/2026/02/04/business/novo-nordisk-wegovy-sales-earnings.html